Back to Search
KISHORE GADDE, M.D.
M.D.
Obesity Medicine (Psychiatry & Neurology) Physician
NPI: 1003979873IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obesity Medicine (Psychiatry & Neurology) PhysicianPrimary
Psychiatry & Neurology — Obesity Medicine
Code: 2084B0002X
MD.207477(LA)
Education
OTHER
Class of 1978
Clinical Trials (1)
1
Linked Trials
1
Recruiting
0
With Results
Research & Publications (20)
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment.
PMID 36752995·Curr Diab Rep·2023
6-review
Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods.
PMID 19675667·PLoS One·2009
1-meta
Rational design of a combination medication for the treatment of obesity.
PMID 18997675·Obesity (Silver Spring)·2009
4-observational
Combination therapy for obesity and metabolic disease.
PMID 19625958·Curr Opin Endocrinol Diabetes Obes·2009
6-review
The effect of acute tryptophan depletion on emotional distraction and subsequent memory.
PMID 19628700·Soc Cogn Affect Neurosci·2009
3-trial
Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats.
PMID 18322467·Neuropsychopharmacology·2008
7-preclinical
Childhood socioeconomic status and serotonin transporter gene polymorphism enhance cardiovascular reactivity to mental stress.
PMID 18158371·Psychosom Med·2008
8-other
Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study.
PMID 17854247·J Clin Psychiatry·2007
4-observational
A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.
PMID 17363756·Diabetes Care·2007
4-observational
Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment.
PMID 16855454·J Clin Psychopharmacol·2006
4-observational
Bupropion treatment of olanzapine-associated weight gain: an open-label, prospective trial.
PMID 16855461·J Clin Psychopharmacol·2006
3-trial
Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks.
PMID 16940206·Circulation·2006
8-other
Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
PMID 16418753·Int J Obes (Lond)·2006
2-rct
The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
PMID 15669888·J Clin Psychiatry·2005
3-trial
Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial.
PMID 15876903·J Clin Psychopharmacol·2005
3-trial
Endocannabinoid receptor antagonists and other emerging pharma-cological strategies for weight reduction.
PMID 16503875·Curr Drug Targets Cardiovasc Haematol Disord·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 6400 PERKINS RD
BATON ROUGE, LA 70808 - Phone
- (225) 763-2552
Quick Facts
- NPI
- 1003979873
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 48
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile